Five drugs and medical devices approved by the FDA since Jan. 21:
- Nexletol is Esperion Therapeutics' drug, the first oral non-statin approved to treat high cholesterol in nearly 20 years.
- Palforzia is Aimmune Therapeutics' drug, designed to treat peanut allergies by exposing patients to small amounts of peanut powder.
- Tazverik is Epizyme's drug, the first treatment that specifically targets epithelioid sarcoma, a rare form of soft tissue cancer.
- Micra AV is the world's smallest pacemaker with atrioventricular synchrony, made by Medtronic.
- Tepezza is Horizon Therapeutics' drug, the first designed to treat thyroid eye disease.